Yes but even with the cost blowout no real eps change and based...

First 2771 Last

Share
Profile

Follow
andrewan

73 Posts.

10

17/08/21

16:44

Post #: 55359363
Share

Originally posted by Byron: ↑

Off comsec, I guess this sums it up:-

NeutralSeven West Media(SWM.AX)FY21 results: Higher cost outlook drive downgrades; TV market looking strong in 1H22; Neutral16 August 2021 | 10:59PM AESTSWM reported an in-line FY21 result, with sales/EBITDA/NPAT were +1%/-3%/+2% vs. GSe and in-line with the recently provided guidance. Cash conversion remained weak (GOCF = 64% of EBITDA), while gearing continued to improve (0.95x ND/EBITDA vs. 2.0x at 1H21).The key disappointment was the higher than expected FY22 cost guidance, with SWM expecting costs in the range A$1,175-95mn, well ahead of our prior $1,097mn estimate. The key difference differences vs. our prior expectations relate to: (1) c.$12mn of content production costs (associated with c.$15mn revenue); (2) $12mn higher than expected Olympic costs; (3) $10mn impact of accounting on cloud compute costs; and (4) net $30-40mn increase in underlying content costs.However, partly offsetting this was the stronger FY21 BVOD performance (Rev +66% in FY21), and stronger than expected 1H22 TV bookings trends, with 1Q/2Q22 bookings tracking +60%/low to mid-single digit (ex AFL), well ahead of GSe prior +13%. Given that SWM' target revenue share of 40% is below GSe prior 40.5%, this implies a stronger overall TV market in 1H22 than our +2% forecast (revised +6%) and hence upside risk to our NEC FY22 forecasts. When combined with the lower TV share form SWM in FY21 (35.3% vs. 37% prior) we believe NEC looks well-placed to deliver solid TV revenues in FY21/22 (noting TEN could also be out-performing). NEC reports its FY21 results on Aug 25th.Overall we revise SWM FY22-24 EBITDA -7% to -3% given higher costs, partly offset by improved revenues. However, given lower D&A and interest expense, our FY22-24 NPAT is +1% to +7%. Our 12m TP decreases -5% to A$0.52 in-line with earnings. We remain Neutral.SWM.AX Earnings and ValuationExhibit 1 : We revise SWM FY22-FY24 EPS by +1%/+7%/+7% on greater TV Revenues and lower D&A and Interest Expense, offset by increased costSource: Company data, Goldman Sachs Global Investment ResearchExhibit 2 : Our 12m EV/EBITDA-based SOTP TP for SWM decreases by 5.5% to A$0.52 driven by earningsSWM EV/EBITDA SOTPSource: Goldman Sachs Global Investment ResearchKey risks are: (1) better/worse than expected cost reduction; (2) strong/weaker outlook; and (3) stonger/weaker TV market share gains

Expand

Yes but even with the cost blowout no real eps change and based on their very conservative 4x EV/EBITDA valuation they still get 52c per share - main concern seems to be that Seven cant help themselves to a spendathon to get to number one

SWM Price at posting: 43.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SGP

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

RAD

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

PAM

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

First 2771 Last

Add SWM (ASX) to my watchlist

(20min delay)
Last 16.5¢		Change -0.005(2.94%)		Mkt cap ! $253.9M

Open	High	Low	Value	Volume
17.0¢	17.0¢	16.0¢	$125.3K	775.9K

Buyers (Bids)

No.	Vol.	Price($)
8	316821	16.0¢

Sellers (Offers)

Price($)	Vol.	No.
16.5¢	102191	2

View Market Depth

No.	Vol.	Price($)
7	202510	0.160
8	623687	0.155
16	348863	0.150
4	281600	0.145
5	60500	0.140

Price($)	Vol.	No.
0.165	23530	1
0.170	1241885	19
0.175	381403	15
0.180	1638510	12
0.185	818323	5

Last trade - 16.10pm 19/11/2024 (20 minute delay)

SWM (ASX) Chart

Yes but even with the cost blowout no real eps change and based...

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Yes but even with the cost blowout no real eps change and based...

Top Stories

Things finally 'looking different' for up-and-down Hot Stock tip Stockland

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News